QuidelOrtho to Participate in 45th Annual Raymond James Institutional Investor Conference
QuidelOrtho Corporation (QDEL) announced its participation in the 45th Annual Raymond James Institutional Investor Conference with its management team including the Interim CEO and President. The event will feature a presentation and fireside chat accessible through a live webcast on the company's Investor Relations page.
02/26/2024 - 04:30 PM
SAN DIEGO --(BUSINESS WIRE)--
QuidelOrtho Corporation (Nasdaq: QDEL) (“QuidelOrtho”), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs and transfusion medicine, today announced that members of its management team are scheduled to participate in the 45th Annual Raymond James Institutional Investor Conference on March 5, 2024, in Orlando, FL.
Recently named Interim Chief Executive Officer, Michael Iskra, and Interim President, Robert Bujarski, will join Chief Financial Officer, Joseph Busky, in a brief presentation followed by a fireside chat at 4 p.m. ET / 1 p.m. PT.
Interested parties can access the live webcast and replay in the “Events & Presentations” section of the “Investor Relations” page of QuidelOrtho’s website at https://ir.quidelortho.com/ .
About QuidelOrtho Corporation
QuidelOrtho Corporation (Nasdaq: QDEL) is a world leader in in vitro diagnostics, developing and manufacturing intelligent solutions that transform data into understanding and action for more people in more places every day.
Offering industry-leading expertise in immunoassay and molecular testing, clinical chemistry and transfusion medicine, bringing fast, accurate and reliable diagnostics when and where they are needed – from home to hospital, lab to clinic. So that patients, clinicians and health officials can spot trends sooner, respond quicker and chart the course ahead with accuracy and confidence.
Building upon its many years of groundbreaking innovation, QuidelOrtho continues to partner with customers across the healthcare continuum and around the globe to forge a new diagnostic frontier. One where insights and solutions know no bounds, expertise seamlessly connects and a more informed path is illuminated for each of us.
QuidelOrtho is advancing diagnostics to power a healthier future.
For more information, please visit www.quidelortho.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20240226717500/en/
Investor Contact:
IR@quidelortho.com
Media Contact:
media@quidelortho.com
Source: QuidelOrtho Corporation
QuidelOrtho Corporation is scheduled to participate in the 45th Annual Raymond James Institutional Investor Conference on March 5, 2024.
The members of QuidelOrtho's management team participating in the conference include the Interim Chief Executive Officer, Michael Iskra, Interim President, Robert Bujarski, and Chief Financial Officer, Joseph Busky.
Interested parties can access the live webcast and replay of the conference in the 'Events & Presentations' section of the 'Investor Relations' page of QuidelOrtho's website at https://ir.quidelortho.com/.
